Showing 1 - 10 of 3313 for "" with applied filters
07 January 2026 by Homburger - Switzerland
Homburger acted as counsel to Yoda PLC in respect of a new CHF 100 m common bond loan issued by Ultima Capital SA and subscribed for by National Bank of Greece S.A. Ultima Capital SA is a luxury real estate company that holds and develops a portfolio of high-end real estate assets in Switzerland, France and Greece.
01 January 2026 by HortenDahl - Denmark
Horten and DAHL are merging to become HortenDahl. By joining forces, the firms will achieve a truly unique position in the Danish legal market – with almost 250 years of combined history, strong local roots, an international outlook and the capabilities to provide broader and deeper advice to both private and public-sector clients.
01 January 2026 by William Fry
Following on from William Fry's recent new partner appointments, the Firm is delighted to announce the promotion of several key individuals who have demonstrated exceptional dedication and expertise in their respective fields.
01 January 2026 by Karanović & Partners - Serbia
Karanovic & Partners is pleased to announce the promotion of three distinguished team members to the position of Senior Partner,n effective 1 January 2026.
23 December 2025 by Elias Neocleous & Co LLC
The Capital Markets team of Elias Neocleous & Co LLC has successfully advised on the sale of existing shares by Rangeglow Limited, a Cyprus-based entity, in connection with the initial public offering (IPO) of Cris-Tim Family Holding on the Regulated Market, Premium Category of the Bucharest Stock Exchange raising RON 454.35 million.
23 December 2025 by Bär & Karrer - Switzerland
Omnidocs Group ApS (Denmark), a portfolio company of Main Capital Partners and a provider of document creation software, has acquired all shares in officeatwork AG. officeatwork AG is a provider of document creation solutions.
23 December 2025 by Homburger - Switzerland
On December 21, 2025, Windward Bio Group AG, a Swiss-based private, clinical-stage biotechnology company committed to improving outcomes for people living with advanced immunological diseases, announced a licensing agreement between its affiliate, LE2025 Therapeutics AG, and Qyuns Therapeutics Co., Ltd. for the development and commercialization of WIN027 (also known as QX027N), a potential best-in-disease, long-acting bispecific antibody targeting TSLP and IL-13.
22 December 2025 by Radu Tărăcilă Pădurari Retevoescu SCA (RTPR)
RTPR has assisted the private equity fund MidEuropa with respect to Romanian law matters related to the closing of the sale of Regina Maria Group to Mehiläinen, Finland’s largest healthcare and social care provider. The transaction was signed in March 2025 and is the largest ever healthcare services transaction in Central Europe.
17 December 2025 by Bruchou & Funes de Rioja - Argentina
Bruchou & Funes de Rioja advised YPF Energía Eléctrica S.A. (“YPF Luz”) and TCA Tanoira Cassagne advised Banco de Galicia y Buenos Aires S.A., Banco Santander Argentina S.A., Balanz Capital Valores S.A.U., SBS Trading S.A., Banco BBVA Argentina S.A., Adcap Securities Argentina S.A., Banco Patagonia S.A., Banco de la Provincia de Buenos Aires, Global Valores S.A., Industrial Valores S.A., BACS Banco de Crédito y Securitización S.A. y Allaria S.A., as arrangers and placement agents (the “Arrangers and Placement Agents”), in the successful issuance of Class XXIII Notes for an amount of US$45,021,217, denominated and payable in U.S. Dollars in Argentina, with a fixed rate of 6.75% and maturing on December 15, 2028 (the “Notes”).
17 December 2025 by Bruchou & Funes de Rioja - Argentina
Vista Energy Argentina S.A.U. (“Vista”) successfully issued its Class XXIX simple non-convertible notes, denominated, subscribed, and payable in U.S. dollars abroad (the “Additional Notes”). The Additional Notes were issued for a nominal value of US$400,000,000 (four hundred million U.S. dollars) under the global program for the issuance of short, medium, or long-term simple non-convertible notes for a maximum aggregate amount of up to US$3,000,000,000 (three billion U.S. dollars) (or its equivalent in other currencies or value or measurement units).